c4c are pleased to announce the launch of the call for proposals, under the IMI Joint Undertaking call 10 initiative, of clinical trials of medicinal products (CTIMPs) that will answer focused research questions to improve understanding of one or more medicine used by neonates, children and young people in Europe. All call details can be accessed here ‘c4c_CallText_v1.0' , information on the Clinical Trials Supplies Advisory Service that c4c offers and templates required for submission.
The focus of this initiative is to fund studies that are “proof-of-viability” studies for the new c4c network. Applicants will need to outline how they will utilise the grant to undertake the trial using the infrastructure (e.g. clinical trials network across at least 5 countries) provided by the network, as detailed within the call text.
Successful applicants will be sponsored by one of the Beneficiaries of c4c, being a legal entity that has signed Grant Agreement No. 777389 and is bound by the terms and provisions of the Consortium Agreement for Collaborative Network for European Clinical Trials for Children (“c4c Consortium Agreement”). The principal investigator may come from other entities, formally linked with the Beneficiary (e.g. part of the national or speciality network coordinated by the Beneficiary).
How to apply
This call follows a single-step procedure, with an early registration of interest.
Each project team will need to register their interest within a month of the publication of the call, no later than COB on 30th September 2018, by email to email@example.com using the letter of intent that accompanies this call. This will include an abstract that describes the background, rationale, objective(s), aim(s) and the methodology of the planned study.
Applications should be submitted to firstname.lastname@example.org using the template for applications that accompanies this call no later than COB on January 5th 2019.
A summary of each proposal’s evaluation will be made available to the applicant of that proposal.